{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/PFE/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-21T11:26:58.168Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8278,"canonical_name":"PFIZER INC","cik":"0000078003","uei":null,"lei":null,"duns":null,"ticker":"PFE"},"window_days":180,"min_importance":60,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"clinical":33,"contracts":1,"open":1,"dol":2},"count":37,"timeline":[{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04370054","excerpt":"[\"Hemophilia A\"]","importance":60},{"ts":"2026-05-18","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07400653","excerpt":"[\"Obesity\",\"Overweight and/or Obesity\",\"Overweight\",\"Diabetes, Type 2\",\"Type 2 Diabetes\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07013474","excerpt":"[\"COVID-19 Infection\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06698796","excerpt":"[\"Dermatomyositis\",\"Polymyositis\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07028853","excerpt":"[\"Metastatic Castration Sensitive Prostate Cancer (mCSPC)\",\"Hormone Sensitive Prostate Cancer\",\"Prostate Cancer\",\"Cancer of the Prostate\"]","importance":60},{"ts":"2026-05-15","kind":"clinical.trial","reporter":"Pfizer","title":"A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06866405","excerpt":"[\"RSV Infection\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07160244","excerpt":"[\"Healthy\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05623020","excerpt":"[\"Multiple Myeloma\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07543380","excerpt":"[\"Respiratory Syncytial Virus (RSV)\"]","importance":60},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06679140","excerpt":"[\"COVID-19 SARS-CoV-2 Infection\"]","importance":60},{"ts":"2026-05-13","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06873945","excerpt":"[\"Alopecia Areata\"]","importance":60},{"ts":"2026-05-12 16:12:04","kind":"contracts.award","reporter":"Department of Health and Human Services","title":"IGF::OT::IGF","security_title":"PFIZER INC","usd_value":68359693,"accession_number":null,"excerpt":null,"importance":70},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue","security_title":"PHASE2,PHASE3","status":"RECRUITING","accession_number":"NCT06989437","excerpt":"[\"Cachexia\",\"Metastatic Pancreatic Ductal Adenocarcinoma\"]","importance":60},{"ts":"2026-05-12","kind":"clinical.trial","reporter":"Pfizer","title":"Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05568719","excerpt":"[\"Hemophilia A\",\"Hemophilia B\"]","importance":60},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06641466","excerpt":"[\"Menstrual Migraine\"]","importance":60},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07578649","excerpt":"[\"Endometrial Neoplasms\",\"Endometrial Cancer\"]","importance":60},{"ts":"2026-05-11","kind":"clinical.trial","reporter":"Pfizer","title":"Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05156398","excerpt":"[\"Migraine\"]","importance":60},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers","security_title":"PHASE1","status":"TERMINATED","accession_number":"NCT06870487","excerpt":"The trial was terminated for strategic business reasons; the decision was not based on any safety and/or efficacy concerns","importance":80},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children","security_title":"PHASE3","status":"COMPLETED","accession_number":"NCT05634811","excerpt":"[\"Lyme Disease\"]","importance":70},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT02319837","excerpt":"[\"Hormone Sensitive Prostate Cancer\",\"Prostate Cancer\",\"Cancer of the Prostate\"]","importance":60},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT05611801","excerpt":"[\"Hemophilia A\",\"Hemophilia B\"]","importance":60},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07573462","excerpt":"[\"Pneumococcal Disease\"]","importance":60},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.","security_title":"PHASE1,PHASE2","status":"TERMINATED","accession_number":"NCT05896163","excerpt":"Business/Administrative decision to pursue other programs/assets within the oncology portfolio. Not due to any detected safety signals or requests from regulatory authorities.","importance":80},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT07226882","excerpt":"[\"Lyme Borreliosis\"]","importance":60},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT06807268","excerpt":"[\"Eczema\"]","importance":60},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07062965","excerpt":"[\"Breast Cancer\"]","importance":60},{"ts":"2026-05-05","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).","security_title":"PHASE3","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT06551324","excerpt":"[\"Metastatic Castrate Resistant Prostate Cancer (mCRPC)\"]","importance":60},{"ts":"2026-05-04","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults","security_title":"PHASE1,PHASE2","status":"TERMINATED","accession_number":"NCT05703607","excerpt":"Strategic decision made by the company","importance":80},{"ts":"2026-04-28","kind":"clinical.trial","reporter":"Pfizer","title":"A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07029828","excerpt":"[\"Severe Alopecia Areata\"]","importance":60},{"ts":"2026-04-24","kind":"clinical.trial","reporter":"Pfizer","title":"MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma","security_title":"PHASE2","status":"TERMINATED","accession_number":"NCT05090566","excerpt":"A business decision was made by Pfizer to terminate the study and not proceed with the Phase 2 expansion of this study. The reason for study termination is not due to any safety concerns or requests from regulatory authorities.","importance":80},{"ts":"2026-04-23","kind":"clinical.trial","reporter":"Pfizer","title":"A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies","security_title":"PHASE1","status":"TERMINATED","accession_number":"NCT06974734","excerpt":"The trial was terminated for strategic business reasons; the decision was not based on any safety and/or efficacy concerns","importance":80},{"ts":"2026-04-22","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07282665","excerpt":"[\"Clostridioides Difficile Associated Disease\"]","importance":60},{"ts":"2026-04-21","kind":"clinical.trial","reporter":"Pfizer","title":"A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07144280","excerpt":"[\"Non-small Cell Carcinoma\",\"Non-Small Cell Lung Cancer Metastatic\",\"Non-Small Cell Lung Carcinoma\"]","importance":60},{"ts":"2026-04-20","kind":"clinical.trial","reporter":"Pfizer","title":"Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer","security_title":"PHASE2,PHASE3","status":"RECRUITING","accession_number":"NCT07226999","excerpt":"[\"Small Cell Lung Cancer (SCLC)\"]","importance":60},{"ts":"2024-12-31","kind":"open.payments","reporter":"PFIZER INC.","title":"$36564328.0 to 149142 physicians (2024–2024)","security_title":"manufacturer","excerpt":"ELREXFIO","accession_number":"2024","usd_value":36564328,"importance":70},{"ts":"2024-12-31","kind":"dol.form5500","reporter":"PFIZER INC","title":"PFIZER RETIREE MEDICAL PLAN","security_title":"Welfare: 4A4E","excerpt":"Total participants 21450 · plan number 559","accession_number":"20251006091004NAL0008521522001","importance":60},{"ts":"2024-12-31","kind":"dol.form5500","reporter":"PFIZER INC","title":"PFIZER LEGACY RETIREE BENEFITS PLAN","security_title":"Welfare: 4A4B4D4F4L4Q","excerpt":"Total participants 2611 · plan number 586","accession_number":"20251006090643NAL0003188481001","importance":60}]}